Viewing Study NCT01969266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2026-02-03 @ 8:06 PM
Study NCT ID: NCT01969266
Status: COMPLETED
Last Update Posted: 2014-02-13
First Post: 2013-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With Food
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy volunteer View
None PCI-32765 View
None PCI 45227 View
None JNJ-54179060 View
None Pharmacokinetic View